Publications by authors named "Eduardo Sprinz"

Claim this Profile
A
A national cross-sectional analysis of surveillance drug resistance mutations among recently diagnosed antiretroviral naïve Brazilian people with HIV.
Debora Bellini Caldeira, Tania Regina Constant Vergara, Mauro Schechter, Eliana Lima Bicudo, Carmen Andréa Freitas Lopes, Eduardo Sprinz

Lancet Reg Health Am· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of dolutegravir treatment in people living with HIV in Brazil: protocol for the CODE cohort.
Carlos Brites, Estela Luz, Cristiani Stelitano, Fabianna Bahia, Marcus Vinícius Guimarães de Lacerda, Eduardo Sprinz

BMC Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil.
Sue Ann Costa Clemens, Sagida Bibi, Natalie G Marchevsky, Parvinder K Aley, Federica Cappuccini, Eduardo Sprinz

Mayo Clin Proc Innov Qual Outcomes· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study.
Maria Ines Figueroa, Carlos Brites, Diego Cecchini, Aline Ramalho, Jose Luis Francos, Eduardo Sprinz

Clin Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simplification with Boosted Protease Inhibitor-Based ART Versus Maintenance of Conventional ART: Results from a Five-Year Controlled Cohort.
Mateus Swarovsky Helfer, Guilherme Carvalho Serena, Tarsila Vieceli, Eduardo Sprinz

Viruses· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of urine Xpert MTB/RIF ultra in a tuberculosis screening strategy in hospitalized patients with advanced HIV disease: Results from an implementation initiative in Brazil.
Diego R Falci, Alessandro C Pasqualotto, Tarsila Vieceli, Omar Sued, Nicole Reis, Eduardo Sprinz

HIV Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of viral failure after simplification therapy without using integrase inhibitors compared with maintenance of triple antiretroviral therapy: A systematic review and meta-analysis.
Mateus Swarovsky Helfer, Eduardo Sprinz

Braz J Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO Requirements.
Fernando Carvalho Neuenschwander, Ofra Barnett-Griness, Stefania Piconi, Yasmin Maor, Eduardo Sprinz

Microorganisms· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of severely ill patients with AIDS treated with efavirenz or dolutegravir: a multicenter, observational study.
Carlos Brites, Marcus Lacerda, Eduardo Sprinz, Monica Bay, Gustavo Pinto

Front Med (Lausanne)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike.
Wonyeong Jung, Dansu Yuan, Benjamin Kellman, Isabela Garrido da Silva Gonzalez, Ralf Clemens, Eduardo Sprinz

NPJ Vaccines· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1.
Judith A Aberg, Bronagh Shepherd, Marcia Wang, Jose V Madruga, Fernando Mendo Urbina, Eduardo Sprinz

Infect Dis Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
Jane A O'Halloran, Emily R Ko, Kevin J Anstrom, Eyal Kedar, Matthew W McCarthy, Eduardo Sprinz

JAMA· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR).
Jatin Patel, Damon Bass, Albertus Beishuizen, Xavier Bocca Ruiz, Hatem Boughanmi, Eduardo Sprinz

Eur Respir J· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The "Histoplasmosis Porto Alegre manifesto"-Addressing disseminated histoplasmosis in AIDS.
Alessandro C Pasqualotto, Flavio Queiroz-Telles, Alberto Chebabo, Terezinha M J S Leitao, Diego R Falci, Eduardo Sprinz

PLoS Negl Trop Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis.
K Gary Barnette, Michael S Gordon, Domingo Rodriguez, T Gary Bird, Alan Skolnick, Eduardo Sprinz

NEJM Evid· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.
Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, Matthew W McCarthy, Emily R Ko, Eduardo Sprinz

medRxiv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.
Emily R Ko, Kevin J Anstrom, Reynold A Panettieri, Anne M Lachiewicz, Martin Maillo, Eduardo Sprinz

medRxiv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous and Heterologous Boosting of the Chadox1-S1-S COVID-19 Vaccine With the SCB-2019 Vaccine Candidate: A Randomized, Controlled, Phase 2 Study.
Sue Ann Costa Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Filippo Pacciarini

Open Forum Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2848 G/A Gene Polymorphism in HCV+, HIV+, and HCV+/HIV+ Individuals.
Bruna Kulmann-Leal, Joel Henrique Ellwanger, Jacqueline María Valverde-Villegas, Daniel Simon, Camila Guerra Marangon, Eduardo Sprinz

Genet Test Mol Biomarkers· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient Elastography in HIV Infected Patients with Liver Steatosis Identifies a High-Risk Group for Non-Alcoholic Steatohepatitis.
Marina Ferri Pezzini, Hugo Cheinquer, Alexandre de Araujo, Carlos T Schmidt-Cerski, Eduardo Sprinz

Curr HIV Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
Lulu Bravo, Igor Smolenov, Htay Htay Han, Ping Li, Romana Hosain, Eduardo Sprinz

Lancet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
Sue Ann Costa Clemens, Pedro M Folegatti, Katherine R W Emary, Lily Yin Weckx, Jeremy Ratcliff, Eduardo Sprinz

Nat Commun· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: HIV and Viral Co-infections.
Carlos Brites, Álvaro H Borges, Eduardo Sprinz, Kimberly Page

Front Microbiol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1.
Peter Ackerman, Melanie Thompson, Jean-Michel Molina, Judith Aberg, Isabel Cassetti, Eduardo Sprinz

AIDS· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Regis Kreitchmann, Fernando Rocha de Oliveira, Eduardo Sprinz

Braz J Infect Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis